E-Moxclav Susp 457 Mg 70 ml

E-Moxclav Susp 457 Mg 70 ml

Description:

E-Moxclav Susp 457 mg 70 ml is an oral antibiotic suspension containing amoxicillin and clavulanic acid, used for the treatment of a wide range of bacterial infections in adults and children. It belongs to the penicillin group of antibiotics combined with a beta-lactamase inhibitor, making it effective against many beta-lactamase–producing bacteria that are resistant to amoxicillin alone. This prescription-only medicine is commonly used in respiratory, ear, sinus, skin, and urinary tract infections and should always be taken under medical supervision.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing strains of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing H. influenzae and M. catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing H. influenzae and M. catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs) caused by beta-lactamase–producing E. coli, Klebsiella species, and Enterobacter species.
• Other infections where the causative organisms are known or suspected to be susceptible to the amoxicillin–clavulanic acid combination, as determined by a physician.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – exact concentration per 5 ml in this 457 mg/5 ml suspension is not specified in the available data.
• Clavulanic acid (as potassium clavulanate) – exact concentration per 5 ml in this 457 mg/5 ml suspension is not specified in the available data.
• Total labeled strength: 457 mg per standard dose (commonly per 5 ml) – detailed breakdown between amoxicillin and clavulanic acid is not available in the provided information.
• Excipients: flavoring agents, sweeteners, stabilizers, and suspension base – full excipient list and concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• E-Moxclav Susp is for oral use only and must be used exactly as prescribed by a physician.
• Shake the bottle well before each use to ensure uniform suspension.
• Use the provided measuring cup or oral syringe to measure the prescribed dose accurately; do not use household teaspoons.
• Typical dosing is based on the patient’s body weight, age, severity of infection, and kidney function. The exact dose and frequency (e.g., every 8 hours or every 12 hours) must be determined by the doctor.
• It is usually recommended to take the suspension at the start of a meal to improve absorption and reduce gastrointestinal side effects.
• Duration of treatment commonly ranges from 5 to 14 days depending on the type and severity of infection. Do not stop treatment early, even if symptoms improve, unless instructed by your doctor.
• If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not double the dose.
• Do not use in children or adults without medical advice, and do not share this medication with others.

Clinical Benefits:

• Provides broad-spectrum antibacterial activity by combining amoxicillin with clavulanic acid, overcoming resistance due to beta-lactamase–producing organisms.
• Effectively treats common respiratory infections such as bronchitis, pneumonia, sinusitis, and otitis media, helping relieve symptoms like cough, fever, and ear pain.
• Helps control and resolve skin and soft tissue infections, reducing redness, swelling, and pain caused by susceptible bacteria.
• Supports rapid improvement in urinary tract infections by eradicating susceptible bacteria, reducing burning, frequency, and discomfort during urination.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Use with extreme caution in patients with a history of severe allergic reactions (e.g., anaphylaxis) to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems).
• Use cautiously in patients with liver impairment or history of amoxicillin–clavulanate–associated cholestatic jaundice or hepatic dysfunction; this combination has been associated with liver injury in rare cases.
• Adjust dose in patients with renal impairment according to physician guidance.
• Prolonged use may result in overgrowth of non-susceptible organisms, including fungi; if superinfection occurs, appropriate measures should be taken.
• May reduce the effectiveness of oral contraceptives; additional non-hormonal contraceptive methods are advisable during treatment.
• Consult your doctor before use if pregnant or planning pregnancy. Amoxicillin–clavulanic acid is generally used in pregnancy only when clearly needed and prescribed by a physician.
• Consult your doctor before use if breastfeeding; small amounts of amoxicillin and clavulanic acid may be excreted in breast milk and can cause sensitization or gastrointestinal disturbances in the infant.
• Inform your doctor about all other medicines you are taking, especially anticoagulants (e.g., warfarin), allopurinol, methotrexate, or other antibiotics, due to possible interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, abdominal pain, and mild skin rash. Taking the suspension with food may help reduce gastrointestinal discomfort.
• Less common side effects: headache, dizziness, oral or vaginal candidiasis (thrush), and changes in taste.
• Serious side effects (seek immediate medical attention): severe allergic reactions such as rash, itching, swelling of the face or throat, difficulty breathing, severe skin reactions, jaundice (yellowing of skin or eyes), dark urine, persistent vomiting, or severe diarrhea with blood or mucus (possible pseudomembranous colitis).
• If any unusual or persistent side effects occur, stop the medication and contact your doctor promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. After reconstitution (if supplied as dry powder), store the prepared suspension as directed in the package insert; typically in a refrigerator at 2–8°c and use within the period specified by the manufacturer. Do not freeze. Discard any unused suspension after the recommended usage period. Do not use after the expiry date printed on the pack.

Specifications:

• Product type: Oral antibiotic suspension.
• Strength: 457 mg per standard dose (commonly per 5 ml) – detailed amoxicillin/clavulanic acid ratio not available in the provided information.
• Volume: 70 ml bottle.
• Route of administration: Oral.
• Intended users: Adults and children as prescribed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.